Your AI-Trained Oncology Knowledge Connection!

Samer A. Srour, MB, ChB, MS

home / authors / samer-a-srour-mb-chb-ms

Samer A. Srour, MB, ChB, MS, is an assistant professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center.

Articles

ICAM-1 CAR T-Cell Therapy Shows Promise in Aggressive Thyroid Cancers

May 2nd 2025

CAR T Cells Engineered to Target Solid Tumors

Samer A. Srour, MB, ChB, MS

September 23rd 2023

Samer A. Srour, MB, ChB, MS, discusses the design of ALLO-316, an agent investigated in the phase 2 TRAVERSE trial for patients with renal cell carcinoma.

Next Steps for Orca-Q in Patients Undergoing Haplo HSCT

Samer A. Srour, MB, ChB, MS

August 11th 2023

Samer A. Srour, MD, MS, discusses what challenges need to be faced when moving forward with the phase 1 trial of Orca-Q in patients undergoing haploidentical allogeneic hematopoietic stem cell transplantation.

Allogeneic CAR T-Cell Therapy Shows Safety and Efficacy in RCC

Samer A. Srour, MB, ChB, MS

June 28th 2023

Samer A. Srour, MD, discusses the results of the phase 1 TRAVERSE trial of ALLO-316 in patients with advanced renal cell carcinoma.

Srour Discusses Orca-Q in the Haploidentical Stem Cell Transplant Setting

Samer A. Srour, MB, ChB, MS

June 19th 2023

Samer A. Srour, MD, discusses research on Orca-Q for patients undergoing haploidentical allogeneic hematopoietic stem cell transplantation.

Overcoming Challenges With Use of CAR T-Cell Therapy in Solid Tumors

Samer A. Srour, MB, ChB, MS

May 8th 2023

Samer A. Srour, MD, explains the history of researching chimeric antigen receptor T-cell therapy in solid tumors.

Novel Cell Therapy Improves HSCT for Hematologic Malignancies

Samer A. Srour, MB, ChB, MS

April 13th 2023

Samer A. Srour, MD, discusses Orca Q graft and how it’s revolutionized haploidentical allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.

Outcomes of Orca-Q in the Haplo SCT Setting for Hematologic Malignancies

Samer A. Srour, MB, ChB, MS

February 21st 2023

Samer A. Srour, MD, MS, discusses some of the takeaways from the dose-expansion phase of an ongoing phase 1 trial evaluating Orca-Q.